Literature DB >> 1651251

Eye pathology in transgenic mice carrying a MSV-SV 40 large T-construct.

W Götz1, F Theuring, J Favor, R Herken.   

Abstract

Several lines of transgenic mice carrying a transgene construct consisting of the regulatory enhancer element of the Moloney murine sarcoma virus and the Simian virus 40 genome coding for the SV 40 promoter and the large T antigen were established. We describe several abnormalities found in the eyes of transgenic animals of which heritable cataract formation, probably due to disturbances in primary lens fibre differentiation, showed a close correlation to large T antigen expression. Additionally, lenticonus anterior, retinal dysplasia and one case of malignant transformation of lens epithelium were found. The introduction of the deleted MSV-enhancer linked to the large T coding region led to less severe postnatally occurring cataracts. Thus, the partial deletion of the MSV enhancer resulted in differences in the degree of severity of lens disturbances. However, tissue specificity remained constant. Our results indicate that large T antigen seems to play an important role in cataract formation but not in the pathogenesis of retinal dysplasia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651251     DOI: 10.1016/0014-4835(91)90126-y

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  3 in total

1.  Midline brain tumors in MSV-SV 40-transgenic mice originate from the pineal organ.

Authors:  W Götz; F Theuring; W Schachenmayr; H W Korf
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.

Authors:  W Götz; C Schucht; J Roth; F Theuring; R Herken
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

3.  Cataracts in transgenic mice caused by a human papillomavirus type 18 E7 oncogene driven by KRT1-14.

Authors:  Shinje Ghim; A Bennett Jenson; Jason A Bubier; Kathleen A Silva; Richard S Smith; John P Sundberg
Journal:  Exp Mol Pathol       Date:  2008-08-06       Impact factor: 3.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.